NEPHROPLUS

Nephrocare Health Services Ltd.

693.45+19.2 (+2.85%)
21 Aug, 12:00 AM

Annual Reports and Financial Documents

Nephrocare Health Services Ltd. annual reports, quarterly results, earnings call transcripts and investor presentations. All official filings in one place.
2026
Annual ReportsFY 2026
Quarterly Results
Conference Calls
Presentations

Corporate Announcements and Regulatory Filings

Nephrocare Health Services Ltd. BSE/NSE disclosures, board meeting outcomes, insider trading notifications, acquisitions and other regulatory filings.
  1. Memorandum of Understanding /Agreements17 Aug 2026
    Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
    Pursuant to Reg 30 of SEBI Listing Regulations, we hereby inform that Nephrocare Health Services, Phillipines Inc., a step-down wholly-owned subsidiary of the Company has acquired a dialysis ....
  2. AGM13 Aug 2026
    Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
    Declartion of voting results along with scrutinizers report of the 17th AGM of the Company.
  3. Analyst / Investor Meet13 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pursuant to Reg 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an investor conference call as per the disclosure annexed herewith.
  4. Memorandum of Understanding /Agreements13 Aug 2026
    Announcement under Regulation 30 (LODR)-Memorandum of Understanding /Agreements
    Pursuant to Reg 30 of SEBI Listing Regulations, we hereby inform that Nephrocare Health Services, Phillipines Inc., an overseas stepdown wholly-owned subsidiary of the Company has acquired ....
  5. Acquisition12 Aug 2026
    Announcement under Regulation 30 (LODR)-Updates on Acquisition
    Clarification to disclosure under Reg 30 dated May 26, 2026 regarding incorporation of Nephrocare Services Kazakhstan LLP.
  6. AGM12 Aug 2026
    Shareholder Meeting / Postal Ballot-Outcome of AGM
    Summary of proceedings of the 17th AGM of the Company.
  7. Analyst / Investor Meet12 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
    In Continuation to our letter dated July 24, 2026 please find enclosed link of the audio recording of the Investors'' Conference Call held on August 12, 2026 on the Unaudited Standalone ....
  8. Monitoring Agency Report11 Aug 2026
    Announcement under Regulation 30 (LODR)-Monitoring Agency Report
    Pursuant to Reg 32 of SEBI Listing Regulations, read with Reg 41 of SEBI ICDR Regulations, please find enclosed herewith Monitoring Agency Report for quarter ended June 30, 2026.
  9. Outcome without intimation11 Aug 2026
    Board Meeting Outcome for Outcome Of Board Meeting Held On August 11, 2026.
    Please find attached the outcome of Board meeting held on August 11, 2026.
  10. Press Release / Media Release11 Aug 2026
    Announcement under Regulation 30 (LODR)-Press Release / Media Release
    Press release on Un-audited standalone and consolidated financial results for the quarter ended June 30, 2026.
  11. Analyst / Investor Meet10 Aug 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pursuant to Regulation 30 of SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Conference Call as per the disclosure enclosed herewith.
  12. Trading Plan under SEBI (PIT) Regulations, 20155 Aug 2026
    Announcement under Regulation 30 (LODR)-Trading Plan under SEBI (PIT) Regulations, 2015
    Please find enclosed the Trading Plans dated August 05, 2026 received from Designated Persons of the company and same have been approved by the compliance officer.
  13. Analyst / Investor Meet24 Jul 2026
    Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
    Pursuant to Regulation 30 of the SEBI Listing Regulations, we hereby inform you that the Company has scheduled an Investor Result Conference Call on Wednesday, 12th August, 2026 at 10:00 ....
  14. Board Meeting24 Jul 2026
    Board Meeting Intimation for The Company Has Informed BSE That The Meeting Of The Board Of Directors Is Scheduled On 11/08/2026 ,Inter Alia, To Consider And Approve The Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter Ended June 30, 2026.
    Nephrocare Health Services Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 11-08-2026 ,inter alia, to consider and approve the Unaudited Standalone ....
  15. Newspaper Publication17 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper Publication regarding Notice on 17th Annual General Meeting and information on remote e-voting.
  16. General16 Jul 2026
    Disclosure Under Regulation 36(1)(B) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015 (''SEBI Listing Regulations'')
    Dispatch of letter providing a web-link of the Annual Report for the FY 2025-26 along with AGM notice.
  17. AGM16 Jul 2026
    Notice Of 17Th Annual General Meeting Of The Company To Be Held On Wednesday, August 12, 2026.
    Notice of 17th Annual General Meeting of the Company to be held on Wednesday, August 12, 2026.
  18. Reg. 34 (1) Annual Report16 Jul 2026
    Reg. 34 (1) Annual Report.
    Annual Report for the FY 2025-26 including Notice of the 17th Annual General Meeting of the Company.
  19. Newspaper Publication16 Jul 2026
    Announcement under Regulation 30 (LODR)-Newspaper Publication
    Newspaper publication titled 17th Annual General Meeting of the Company through Video conferencing / Other Audio Visual Means, Cut-Off date information.
  20. Allotment of ESOP / ESPS15 Jul 2026
    Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS
    Pursuant to Reg 30 of SEBI Listing Regulations, 2015, we hereby inform that the Company has approved allotment of 2,18,297 equity shares of face value of Rs. 2/- each, pursuant to the exercise ....

Frequently Asked Questions

Where can I download the annual report of Nephrocare Health Services Ltd.?
Annual reports of Nephrocare Health Services Ltd. are available for download in the Annual Reports and Financial Documents section of the Resources tab, organised by financial year.
Where can I find the quarterly results of Nephrocare Health Services Ltd.?
Quarterly earnings results and presentations of Nephrocare Health Services Ltd. are available in the Annual Reports and Financial Documents section of the Resources tab. Detailed financials are also in the Statements tab.
Does Nephrocare Health Services Ltd. publish earnings call transcripts?
Earnings call transcripts of Nephrocare Health Services Ltd., where available, are listed in the Annual Reports and Financial Documents section of the Resources tab.
Where can I find investor presentations of Nephrocare Health Services Ltd.?
Investor presentations and annual day presentations of Nephrocare Health Services Ltd. are listed in the Resources tab under Annual Reports and Financial Documents.
What are the recent corporate announcements of Nephrocare Health Services Ltd.?
Corporate announcements and regulatory filings of Nephrocare Health Services Ltd. as submitted to BSE and NSE are available in the Corporate Announcements and Regulatory Filings section of the Resources tab.
How do I access the regulatory filings of Nephrocare Health Services Ltd.?
Regulatory filings including board meeting outcomes, insider trading disclosures and other exchange notifications of Nephrocare Health Services Ltd. are in the Corporate Announcements and Regulatory Filings section of the Resources tab.
What is the ISIN of Nephrocare Health Services Ltd.?
The ISIN (International Securities Identification Number) of Nephrocare Health Services Ltd. is INE428V01029. This is the unique identifier used across exchanges and depositories.
On which stock exchange is Nephrocare Health Services Ltd. listed?
Nephrocare Health Services Ltd. is listed on NSE and BSE. The NSE symbol is NEPHROPLUS and the BSE code is -.
Where can I find the shareholding pattern of Nephrocare Health Services Ltd.?
The quarterly shareholding pattern of Nephrocare Health Services Ltd. showing promoter, FII, DII, mutual fund and public holdings is available in the Shareholding Pattern section on the Overview tab.
How current is the data for Nephrocare Health Services Ltd. on Sharpely?
Share price data for Nephrocare Health Services Ltd. is updated as of 21 Aug 2026. Financial statements, shareholding and other fundamental data are updated after each quarterly disclosure.